Symbol="JANX"
AssetType="Common Stock"
Name="Janux Therapeutics Inc"
Description="Janux Therapeutics, Inc., a biopharmaceutical company, develops therapies based on the patented Tumor Activated T Cell Engager (TRACTr) platform technology to treat cancer patients. The company is headquartered in La Jolla, California."
CIK="1817713"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="11099 TORREY PINES PARK ROAD, SAN DIEGO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="507020000"
EBITDA="-72617000"
PERatio="None"
PEGRatio="None"
BookValue="7.45"
DividendPerShare="0"
DividendYield="0"
EPS="-1.6"
RevenuePerShareTTM="0.218"
ProfitMargin="0"
OperatingMarginTTM="-8.14"
ReturnOnAssetsTTM="-0.128"
ReturnOnEquityTTM="-0.201"
RevenueTTM="9071000"
GrossProfitTTM="-44829000"
DilutedEPSTTM="-1.6"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.289"
AnalystTargetPrice="27.5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="71.67"
PriceToBookRatio="1.697"
EVToRevenue="33.56"
EVToEBITDA="-4.025"
Beta="1.477"
num_52WeekHigh="23.64"
num_52WeekLow="10"
num_50DayMovingAverage="12.73"
num_200DayMovingAverage="14.73"
SharesOutstanding="41833300"
DividendDate="None"
ExDividendDate="None"
symbol="JANX"
open="12.12"
high="12.84"
low="12.00"
price="12.49"
volume="327554.00"
latest_trading_day="2023-07-18"
previous_close="12.12"
change="0.37"
change_percent="3.0528%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="65"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="35"
Volume_recent_avg="115306"
Change_recent_avg="-0.06"
Delta_recent_avg="0.99"
Variance_recent_avg="0.49"
Change_ratio_recent_avg="-0.55"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="35"
Aroon_momentum_negative="65"
image_negative_thumbnail_id_1="1086"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0119.jpeg"
image_negative_thumbnail_id_2="1147"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0180.jpeg"
image_neutral_thumbnail_id_1="596"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0003.jpeg"
image_neutral_thumbnail_id_2="550"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0049.jpeg"
image_positive_thumbnail_id_1="677"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0031.jpeg"
image_positive_thumbnail_id_2="998"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0160.jpeg"
image_professor_thumbnail_id_1="1188"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0022.jpeg"
image_professor_thumbnail_id_2="1173"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0007.jpeg"
